MX2009008686A - Uso de quitosanos para aumentar el indice de crecimiento de las uñas. - Google Patents

Uso de quitosanos para aumentar el indice de crecimiento de las uñas.

Info

Publication number
MX2009008686A
MX2009008686A MX2009008686A MX2009008686A MX2009008686A MX 2009008686 A MX2009008686 A MX 2009008686A MX 2009008686 A MX2009008686 A MX 2009008686A MX 2009008686 A MX2009008686 A MX 2009008686A MX 2009008686 A MX2009008686 A MX 2009008686A
Authority
MX
Mexico
Prior art keywords
nail
growth rate
chitosans
nail growth
increase nail
Prior art date
Application number
MX2009008686A
Other languages
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009008686(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MX2009008686A publication Critical patent/MX2009008686A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere al uso de quitosano, un derivado de quitosano o de una sal fisiológicamente aceptable de los mismos, para aumentar el índice del crecimiento de uña. La invención además se refiere al uso de quitosanos para acelerar el índice del crecimiento de uña durante el tratamiento de las enfermedades de uña, distrofia de uña u otras condiciones de la uña, para acortar considerablemente los tratamientos específicos de las enfermedades de uña, distrofia de uña u otras condiciones de la uña.
MX2009008686A 2007-02-14 2008-02-07 Uso de quitosanos para aumentar el indice de crecimiento de las uñas. MX2009008686A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (en) 2007-02-14 2007-02-14 Use of chitosans to increase nail growth rate
PCT/EP2008/051477 WO2008098869A2 (en) 2007-02-14 2008-02-07 Use of chitosans to increase nail growth rate

Publications (1)

Publication Number Publication Date
MX2009008686A true MX2009008686A (es) 2009-08-21

Family

ID=38345983

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008686A MX2009008686A (es) 2007-02-14 2008-02-07 Uso de quitosanos para aumentar el indice de crecimiento de las uñas.

Country Status (32)

Country Link
US (3) US8680074B2 (es)
EP (3) EP1958638A1 (es)
JP (3) JP5426401B2 (es)
KR (2) KR101323762B1 (es)
CN (2) CN101663039B (es)
AR (1) AR065316A1 (es)
AT (1) ATE522221T1 (es)
AU (1) AU2008214693B2 (es)
BR (1) BRPI0807595A2 (es)
CA (1) CA2677715C (es)
CL (2) CL2008000444A1 (es)
CO (1) CO6230979A2 (es)
CY (2) CY1112058T1 (es)
DK (2) DK2117564T3 (es)
EA (2) EA201270116A1 (es)
ES (2) ES2369116T3 (es)
HK (1) HK1133189A1 (es)
HR (2) HRP20110667T1 (es)
IL (1) IL200269A (es)
MA (1) MA31236B1 (es)
ME (1) ME00830B (es)
MX (1) MX2009008686A (es)
MY (2) MY163297A (es)
NZ (1) NZ578896A (es)
PH (1) PH12014500274A1 (es)
PL (2) PL2117564T3 (es)
PT (2) PT2117564E (es)
RS (2) RS52031B (es)
SI (2) SI2377541T1 (es)
UA (1) UA100011C2 (es)
WO (1) WO2008098869A2 (es)
ZA (1) ZA200905443B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
CN103987370A (zh) * 2011-10-05 2014-08-13 阿勒根公司 用于增进指甲健康的组合物
EP2793946B1 (fr) * 2011-12-20 2019-03-06 Urgo Recherche Innovation et Développement Composition topique filmogène et son utilisation pour traiter ou prévenir l'onychophagie
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
ES2101263T3 (es) 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
PT1455802E (pt) * 2001-12-14 2008-11-03 Dnp Canada Inc Oligossacáridos de quitosano e suas utilizações
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
UA100011C2 (ru) 2012-11-12
EA018390B1 (ru) 2013-07-30
SI2377541T1 (sl) 2014-01-31
AR065316A1 (es) 2009-05-27
KR20090121312A (ko) 2009-11-25
ME00830B (me) 2012-03-20
CN102988405A (zh) 2013-03-27
MY163297A (en) 2017-09-15
JP2015221823A (ja) 2015-12-10
CN101663039B (zh) 2013-08-07
EP2117564A2 (en) 2009-11-18
SI2117564T1 (sl) 2011-12-30
RS52031B (en) 2012-04-30
CA2677715C (en) 2014-10-14
KR101323762B1 (ko) 2013-11-01
CA2677715A1 (en) 2008-08-21
KR20110075043A (ko) 2011-07-05
EP2377541A1 (en) 2011-10-19
CO6230979A2 (es) 2010-12-20
EP2377541B1 (en) 2013-10-23
WO2008098869A2 (en) 2008-08-21
EP1958638A1 (en) 2008-08-20
CN101663039A (zh) 2010-03-03
ES2369116T3 (es) 2011-11-25
MA31236B1 (fr) 2010-03-01
MY154499A (en) 2015-06-30
HRP20131175T1 (hr) 2014-01-17
EA200901093A1 (ru) 2010-02-26
EP2117564B1 (en) 2011-08-31
AU2008214693A1 (en) 2008-08-21
ATE522221T1 (de) 2011-09-15
US20100152133A1 (en) 2010-06-17
IL200269A0 (en) 2010-04-29
US9173827B2 (en) 2015-11-03
JP2013213048A (ja) 2013-10-17
WO2008098869A3 (en) 2008-10-09
AU2008214693A2 (en) 2009-09-10
CL2013002052A1 (es) 2014-02-21
US20160015620A1 (en) 2016-01-21
CL2008000444A1 (es) 2008-08-22
RS53143B (en) 2014-06-30
PH12014500274A1 (en) 2016-06-06
JP5426401B2 (ja) 2014-02-26
HK1133189A1 (en) 2010-03-19
BRPI0807595A2 (pt) 2014-07-22
JP6045663B2 (ja) 2016-12-14
JP2010518138A (ja) 2010-05-27
CY1112058T1 (el) 2015-11-04
PL2377541T3 (pl) 2014-04-30
DK2117564T3 (da) 2011-10-17
PT2377541E (pt) 2013-11-21
DK2377541T3 (da) 2013-11-11
ES2436647T3 (es) 2014-01-03
AU2008214693B2 (en) 2013-05-02
HRP20110667T1 (hr) 2011-10-31
IL200269A (en) 2015-10-29
NZ578896A (en) 2012-02-24
CY1115136T1 (el) 2016-12-14
US20140147401A1 (en) 2014-05-29
PT2117564E (pt) 2011-10-17
ZA200905443B (en) 2010-10-27
KR101131015B1 (ko) 2012-03-29
EA201270116A1 (ru) 2012-06-29
US8680074B2 (en) 2014-03-25
PL2117564T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
PH12014500274A1 (en) Use of chitosans to increase nail growth rate
WO2016105525A3 (en) Novel pyrimidines as egfr inhibitors and methods of treating disorders
MY169980A (en) Bisaryl-linked aryltriazolones and their use
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
CA2770066C (en) Prostacyclin, analogue or derivative thereof for the treatment of cystic fibrosis
NZ599928A (en) Use of pentosan polysulfate for treatment or prophylaxis of asthma
WO2010121675A3 (en) Thiazolyl-benzimidazoles
EA024696B9 (ru) Способ обработки волос
WO2010025135A3 (en) Trimeprazine and ethopropazine derivatives for promoting bone growth
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2010006443A (es) TRATAMIENTO DE CARDIOPATIAS USANDO ß-BLOQUEANTES.
IN2014DN09240A (es)
WO2010046865A3 (en) Ophthalmic administration of a composition including brimonidine as a mist
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use
MY166065A (en) Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases
WO2010011599A3 (en) Pimethixene derivatives for promoting bone growth
WO2012008763A3 (en) Composition for preventing hair loss and stimulating hair growth
WO2010019549A3 (en) Indoprofen derivatives for promoting bone growth
RU2007139427A (ru) Способ предпосевной обработки семян овощных культур
HK1131990A1 (en) Derivatives of 5-thioxylopyranose and use of same for treatment
WO2008034895A3 (en) Ansamycin derivatives
UA43018U (en) Method for immunocorrection of chronic polypous ethmoiditis
UA43017U (ru) Способ лечения хронического полипозного этмоидита
WO2013079204A3 (en) 4-phenylbutyric acid for cosmetic use

Legal Events

Date Code Title Description
FG Grant or registration